__timestamp | Pfizer Inc. | Takeda Pharmaceutical Company Limited |
---|---|---|
Wednesday, January 1, 2014 | 40028000000 | 1256834000000 |
Thursday, January 1, 2015 | 39203000000 | 1271973000000 |
Friday, January 1, 2016 | 40495000000 | 1173296000000 |
Sunday, January 1, 2017 | 41306000000 | 1274610000000 |
Monday, January 1, 2018 | 42399000000 | 1437534000000 |
Tuesday, January 1, 2019 | 41531000000 | 2201424000000 |
Wednesday, January 1, 2020 | 33216000000 | 2203504000000 |
Friday, January 1, 2021 | 50467000000 | 2462160000000 |
Saturday, January 1, 2022 | 65986000000 | 2783406000000 |
Sunday, January 1, 2023 | 28809000000 | 2832257000000 |
Monday, January 1, 2024 | 45776000000 | 2832257000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. Over the past decade, Pfizer Inc. and Takeda Pharmaceutical Company Limited have showcased distinct trajectories in their gross profit margins. From 2014 to 2023, Pfizer's gross profit fluctuated, peaking in 2022 with a remarkable 65% increase from its 2014 figures. However, 2023 saw a significant dip, highlighting the volatility in the market.
Conversely, Takeda Pharmaceutical demonstrated a more consistent upward trend, with its gross profit nearly doubling from 2014 to 2023. This growth underscores Takeda's strategic positioning and resilience in the global market. Notably, 2019 marked a pivotal year for Takeda, with a substantial 54% increase in gross profit, likely driven by strategic acquisitions and expansions.
These insights provide a window into the financial health and strategic maneuvers of two pharmaceutical giants, offering valuable lessons for investors and industry stakeholders.
Gross Profit Trends Compared: Novo Nordisk A/S vs Takeda Pharmaceutical Company Limited
Gross Profit Comparison: AbbVie Inc. and Takeda Pharmaceutical Company Limited Trends
Who Generates Higher Gross Profit? Pfizer Inc. or Alnylam Pharmaceuticals, Inc.
Pfizer Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Amgen Inc. and Takeda Pharmaceutical Company Limited
Zoetis Inc. and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs HUTCHMED (China) Limited
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis